Albaconazole (development code UR-9825) is an experimental triazole antifungal.[1] It has potential broad-spectrum activity. The drug blocks a number of CYP450 liver enzymes.[citation needed]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.170.829 |
Chemical and physical data | |
Formula | C20H16ClF2N5O2 |
Molar mass | 431.83 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
It has also been studied as an antiprotozoal agent.[2]
References
edit- ^ "Albaconazole". Adis Insight. Springer Nature Switzerland AG.
- ^ Guedes PM, Urbina JA, de Lana M, Afonso LC, Veloso VM, Tafuri WL, et al. (November 2004). "Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts". Antimicrobial Agents and Chemotherapy. 48 (11): 4286–92. doi:10.1128/AAC.48.11.4286-4292.2004. PMC 525424. PMID 15504854.